What is Bicara Therapeutics's compensation and benefits?

Bicara Therapeutics (BCAX) reported compensation and benefits of $1.91M in Q1 2026.

How has Bicara Therapeutics's compensation and benefits changed year-over-year?

Bicara Therapeutics's compensation and benefits increased by 14.1% year-over-year, from $1.68M to $1.91M.

What is the long-term trend for Bicara Therapeutics's compensation and benefits?

Over 2 years (2023 to 2025), Bicara Therapeutics's compensation and benefits has grown at a 70.1% compound annual growth rate (CAGR), from $1.74M to $5.04M.

Bicara Therapeutics BCAX Compensation and benefits

Compensation and benefits at other companies

Eli LillyLLY

——

Inhibrx Biosciences, Inc.INBX

——

Arcus BiosciencesRCUS

——

Viridian Therapeutics, Inc.VRDN

——

Summit TherapeuticsSMMT

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's compensation and benefits?: Bicara Therapeutics (BCAX) reported compensation and benefits of $1.91M in Q1 2026.
How has Bicara Therapeutics's compensation and benefits changed year-over-year?: Bicara Therapeutics's compensation and benefits increased by 14.1% year-over-year, from $1.68M to $1.91M.
What is the long-term trend for Bicara Therapeutics's compensation and benefits?: Over 2 years (2023 to 2025), Bicara Therapeutics's compensation and benefits has grown at a 70.1% compound annual growth rate (CAGR), from $1.74M to $5.04M.